Korean J Dermatol.
2013 Feb;51(2):155-157.
Ulcerated Perianal Infantile Hemangioma Treated with Propranolol
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Soonchunhyang University, Cheonan, Korea. dermsung@schmc.ac.kr
- 2Department of Pediatrics, College of Medicine, Soonchunhyang University, Cheonan, Korea.
Abstract
- Infantile hemangioma is a self-resolving benign tumor that commonly requires no intervention. Despite its distinctive, self-limiting course, infantile hemangiomas may result in ulcerations that cause pain, potential scarring, bleeding, and infection. Active treatment is usually required to manage these lesions. The discovery of propranolol in the treatment of infantile hemangioma was described in 2008 by Leaute-Labreze, et al. Since then, its effectiveness and safety have been confirmed by several cases, and replacing systemic corticosteroids as a first-line therapy. Herein, we report the successful treatment of children with ulcerated perianal infantile hemangioma with propranolol.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Giant Infantile Hemangioma Treated with Beta-blocker with Intermittent Triamcinolone Intralesional Injection
- Three Cases of Infantile Hemanioma Treated with Topical Timolol
- Infantile Hemangioma Presenting as Perianal Ulcers
- Ulcerative Infantile Hemangioma Treated with Topical Timolol
- Update on recent research into infantile hemangioma
